Pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen

Biochemical and Biophysical Research Communications

Volumn 419, Issue 1, 2012, Pages 7-13

  Matsumoto, Yasuyuki ^a   Zhang, Qing ^a   Akita, Kaoru ^b   Nakada, Hiroshi ^b   Hamamura, Kazunori ^a   Tokuda, Noriyo ^a   Tsuchida, Akiko ^a,c   Matsubara, Takeshi ^a   Hori, Tomoko ^a   Okajima, Tetsuya ^a   Furukawa, Keiko ^a,d   Urano, Takeshi ^e   Furukawa, Koichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO SANGYO UNIVERSITY   (Japan)

^c NOGUCHI INSTITUTE   (Japan)

^d CHUBU UNIVERSITY   (Japan)

^e SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

GM1; Invasion; Lung cancer; Metastasis; O glycan; Pp GalNAc T

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MLS128; SYNDECAN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE IDENTIFICATION; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUNG CANCER; LUNG METASTASIS; METASTASIS POTENTIAL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; LAMININ; LUNG NEOPLASMS; MICE; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; PROTEIN MULTIMERIZATION; PROTEOGLYCANS; SYNDECAN-1;

MURINAE; MUS;

EID: 84862818251     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.086     Document Type: Article

References (26)

1. Harlozinska A. Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Res. 2005, 25:3327-3333.
2. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj. J. 2004, 20:353-364.
3. Ellis L.M. Angiogenesis and its role in colorectal tumor and metastasis formation. Semin. Oncol. 2004, 31:3-9.
4. Nathanson S.D. Insight into the mechanisms of lymph node metastasis. Cancer 2003, 98:413-423.
5. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat. Rev. 2005, 5:735-743.
6. Bjorklund M., Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta 2005, 1755:37-69.
7. Zhang Q., Furukawa K., Chen H.H., Sakakibara T., Urano T., Furukawa K. Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating matrix metalloprotease-9 localization in lipid rafts. J. Biol. Chem. 2006, 281:18145-18155.
8. Tian E., Ten Hagen E.K.G. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj. J. 2009, 26:325-334.
9. E.P. Bennett, U. Mandel, H. Clausen, T.A. Gerken, T.A. Fritz, L.A. Tabak, Control of mucin-type O-glycosylation - a classification of the polypeptide galnac- transferase gene family. Glycobiology (2011) in press. [Epub ahead of print].
10. Zhang Y., Iwasaki H., Wang H., Kudo T., Kalka T.B., Hennet T., Kubota T., Cheng L., Inaba N., Gotoh M., Togayachi A., Guo J., Narimatsu H. Cloning and characterization of a new human UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyl-transferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen. J. Biol. Chem. 2003, 278:573-584.
11. Numata Y., Nakada H., Fukui S., Kitagawa H., Ozaki K., Inoue M., Kawasaki T., Funakoshi I., Yamashita I. A monoclonal antibody directed to Tn antigen. Biochem. Biophys. Res. Commun. 1990, 170:981-985.
12. Van den Steen P., Rudd P.M., Dwek R.A., Opdenakker G. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 1998, 33:151-208.
13. Wang Y., Agrwal N., Eckhardt A.E., Stevens R.D., Hill R.L. The acceptor substrate specificity of porcine submaxillary UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase is dependent on the amino acid sequences adjacent to serine and threonine residues. J. Biol. Chem. 1992, 267:12709-12716.
14. Brockhausen I., Yang J.M., Burchell J., Whitehouse C., Taylor-Papadimitriou J. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem. 1995, 233:607-617.
15. Schachter H., Brockhausen I. The biosynthesis of branched O-glycans. Symp. Soc. Exp. Biol. 1989, 43:1-26.
16. Springer G.F. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J. Mol. Med. 1997, 75:594-602.
17. Wang B.L., Springer G.F., Carlstedt S.C. Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma. J. Histochem. Cytochem. 1997, 45:1393-1400.
18. Imai J., Ghazizadeh M., Naito Z., Asano G. Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma. Anticancer Res. 2001, 21:1327-1334.
19. Lloyd K.O., Burchell J., Kudryashov V., Yin B.W., Taylor-Papadimitriou J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J. Biol. Chem. 1996, 271:33325-33334.
20. Lui J., Yang L., Jin M., Xu L., Wu S. Regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2. Mol. Med. Report 2011, 4:1299-1305.
21. Taniuchi K., Cerny R.L., Tanouchi A., Kohno K., Kotani N., Honke K., Saibara T., Hollingsworth M.A. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene 2011, 30:4843-4854.
22. Park J.H., Nishidate T., Kojima K., Ohashi T., Takegawa K., Fujikane T., Hirata K., Nakamura Y., Katagiri T. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res. 2010, 70:2759-2769.
23. Berois N., Blanc E., Ripoche H., Mergui X., Trajtenberg F., Cantais S., Barrois M., Dessen P., Kågedal B., Bénard J., Osinaga E., Raguénez G. PpGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma. Clin. Chem. 2006, 52:1701-1712.
24. Fu J., Gerhardt H., McDaniel J.M., Xia B., Liu X., Ivanciu L., Ny A., Hermans K., Silasi-Mansat R., McGee S., Nye E., Ju T., Ramirez M.I., Carmeliet P., Cummings R.D., Lupu F., Xia L. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J. Clin. Invest. 2008, 118:3725-3737.
25. Wang Y., Ju T., Ding X., Xia B., Wang W., Xia L., He M., Cummings R.D. Cosmc is an essential chaperone for correct protein O-glycosylation. Proc. Natl. Acad. Sci. USA 2010, 107:9228-9233.
26. Wagner K.W., Punnoose E.A., Januario T., Lawrence D.A., Pitti R.M., Lancaster K., Lee D., von Goetz M., Yee S.F., Totpal K., Huw L., Katta V., Cavet G., Hymowitz S.G., Amler L., Ashkenazi A. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 2007, 13:1070-1077.